marijuana stock news

Growblox Sciences, Inc. (GBLX)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue –   –   –   –  
Cost of Revenue – – – –
Gross Profit –   –   –   –  
Operating Expenses
Research Development – – – –
Selling General and Administrative 678 1,780 1,495 131
Non Recurring – – – –
Others – – – –
Total Operating Expenses – – – –
Operating Income or Loss (678) (1,780) (1,495) (131)
Income from Continuing Operations
Total Other Income/Expenses Net (0) 0 0 (559)
Earnings Before Interest And Taxes (678) (1,780) (1,495) (132)
Interest Expense – – – 14
Income Before Tax (678) (1,780) (1,495) (146)
Income Tax Expense – – – –
Minority Interest 56 110 50 –
Net Income From Continuing Ops (622) (1,670) (1,445) (705)
Non-recurring Events
Discontinued Operations – – – –
Extraordinary Items – – – –
Effect Of Accounting Changes – – – –
Other Items – – – –
Net Income (622) (1,670) (1,445) (705)
Preferred Stock And Other Adjustments – – – –
Net Income Applicable To Common Shares (622) (1,670) (1,445) (705)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Cresco Labs (CRLBF) Announces Voting Results of Its Annual Meeting of Shareholders

Cresco Labs Announces Voting Results of Its Annual Meeting of Shareholders Cresco…

Global Consortium, Inc., (GCGX) is exploring opportunities in Canada

Global Consortium, Inc., is exploring opportunities in Canada Global Consortium, Inc., (GCGX)…

$TAUG Granted Additional Funding from Tokyo Based Dragoon Capital, Inc.

Tauriga Sciences Inc. Receives Additional $150,000 USD Private Placement Tranche from Tokyo…

$INSY Reports Second Quarter 2015 Results

Insys Therapeutics Reports Second Quarter 2015 Results  Insys Therapeutics, Inc. (NASDAQ: INSY)…